Skip to main content
SPARC - Logo
Innovations Inspired by life
Menu

Hamburger

  • Our Company
    • Who we are
    • History
    • Culture
    • Board of Directors
    • Leadership Team
  • OUR RESEARCH
    • Therapeutic focus
    • Delivery Technologies
    • Research Programs
    • R&D Pipeline
  • Our Medicines
    • Xelpros®
    • Elepsia® XR
  • Business Development
    • Strategy
    • Partner with us
  • Accreditations And Approvals
    • Good Laboratory Practice
  • Investors
    • Who we are
    • Financials
    • Annual reports
    • Presentations
    • Chairman's Speech
    • Committees of BOD's
    • Shareholding pattern
    • Announcements & Disclosures
    • Policies & Codes
    • Listing Information
    • Board of Directors
    • FAQ’s
    • Investors Contact
    • Go green
    • IEPF
  • Media
    • Press Releases
    • Presentations
  • Careers
    • Overview
    • Apply Now
  • Contact Us
Media » Press Releases
  • Media
    • Press Releases
    • Presentations

Press Releases

  • 14-Oct-2020
    SPARC Announces Positive Top-line Results from Pivotal Phase 3 Clinical Trial of SDN-037 for the Treatment of Inflammation and Pain Associated with Ocular Surgery
  • 22-Sep-2020
    SPARC Licenses Commercialization Rights of ElepsiaTM XR to Tripoint Therapeutics
  • 19-Aug-2020
    SPARC to Provide Update on R&D Pipeline
  • 28-May-2020
    SPARC enters into a worldwide license agreement for SCD-044 with Sun Pharma
  • 13-Feb-2020
    SPARC to Provide Update on TaclantisTM NDA
  • 19-Dec-2019
    SPARC acquires Bioprojet’s rights for SCD-044
  • 09-Dec-2019
    SPARC Provides Update on Paclitaxel Injection Concentrate for Suspension (PICS) Litigation
  • 05-Nov-2019
    SPARC Enters into a Licensing Deal with CMS
  • 22-Aug-2019
    SPARC to Provide Update on R&D Pipeline
  • 08-Jul-2019
    SPARC Receives Orphan Drug Designation from the USFDA for SCO-088 for the Treatment of Patients with Chronic Myeloid Leukemia

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Next page ››
  • Last page Last »

Our Company

  • Who we are
  • history
  • Culture
  • board of directors
  • Leadership team

Our Research

  • Therapeutic focus
  • Delivery Technologies
  • Research Programs
  • R&D Pipeline

Investor Relations

  • Financials
  • Announcements & Disclosures
  • Shareholding pattern
  • Listing Information

Quick Links

Quick Links

  • Business Development
  • Investors
  • Media
  • Careers

Social Connect

  • twitter
  • linkedin

Employee Portal »

Copyright © 2019. Sun Pharma Advanced Research Company Ltd. All rights reserved.
Terms of Use  |   Archival Policy   |   Sitemap
Site Credits